We are thrilled to announce the promotion of Betsy Gutierrez to Senior Vice President of Quality! Betsy has been an invaluable asset to our team for over 8 years, consistently demonstrating exceptional leadership and dedication. Her expertise has been instrumental in driving our quality initiatives forward and serving as a trusted partner internally and externally. Please join #Rani in congratulating Betsy on this well-deserved promotion! #promotion #leadership #qualityassurance #RaniPill
关于我们
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill? technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill? capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.
- 网站
-
https://ranitherapeutics.com
Rani Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- San Jose，California
- 类型
- 上市公司
- 创立
- 2012
地点
-
主要
获取路线
2051 Ringwood Avenue
US，California，San Jose，95131
Rani Therapeutics员工
动态
-
Our Chief Business Officer, Kate Flavin McKinley, and Chief Financial Officer, Svai Sanford, will have the honor of presenting at a fireside chat today at the 2024 Stifel Healthcare Conference.?We are excited for the opportunity to share more on how our #RaniPill platform has the potential to replace subcutaneous injection and intravenous infusion of biologics and drugs with oral dosing. https://lnkd.in/eXThiT4Z
-
-
Our Chief Business Officer, Kate Flavin McKinley, will have the honor of presenting in a fireside chat this week at the 2024 #UBS Global Healthcare Conference.?We are excited for the opportunity to share more on how our #RaniPill platform has the potential to replace subcutaneous injection and intravenous infusion of biologics and drugs with oral dosing. Listen to webcast: https://lnkd.in/gxfvDeap
-
-
On this Veterans Day, we at #RaniTherapeutics express our deepest gratitude to the selfless heroes who have dedicated their lives to protecting our Nation. Their unwavering commitment to service inspires us at Rani Therapeutics to strive for innovation and a safer and healthier future for all.?? Here is to honoring their service and supporting our veterans. #VeteransDay2024 #ThankAVet #Military
-
-
We are incredibly proud to share that our Founder and Chairman of the Board, Mir Imran, has been honored as one of the top 50 Biotech Entrepreneurs of 2024! This recognition highlights his exceptional leadership and innovative contributions to the biotech industry and patient care over many decades. The Top 50 BioTech Entrepreneurs of 2024 - Great Entrepreneurs: https://lnkd.in/gYvy9J6w #biotech #leadership #innovation
-
-
Rani Therapeutics Awarded Great Place to Work for 3 Years in a Row! We are thrilled to announce that Rani Therapeutics has been awarded the Great Place to Work certification for the third year in a row! This is a testament to our commitment to creating a positive and supportive work environment for all of our employees. We believe that our employees are our greatest asset, and we are committed to providing them with the culture, tools and resources they need to be successful. We would like to thank all of our employees for their hard work and dedication. We are proud to have such a talented and passionate team! Go #TeamRani!! #RaniTherapeutics #GreatPlaceToWork #EmployeeRecognition #Culture #RaniPill
-
-
“The pharmacokinetic data announced today combined with the previously announced pharmacodynamic data further highlight the RaniPill’s potential to serve as a novel delivery platform for incretin triagonists, a next generation modality for the treatment of obesity,” said Talat Imran, Chief Executive Officer of Rani Therapeutics. Read more below on the new data announced today and how the #RaniPill has the potential to replace painful injections with oral alternatives. #RaniTherapeutics #GLP #obesity #triagonist https://lnkd.in/gAHQP7Fq
-
?? Exciting News from Rani! We are thrilled to announce the promotion of two outstanding team members to Vice President roles within our senior management team! Ali Javadi, Ph.D. VP, Technical Operations With over 15 years of expertise in technical and operational leadership, and 3 years at Rani, Alireza’s expanded role will include: ? Leading technical R&D, manufacturing and automation teams Kyle Horlen, DVM VP, Nonclinical Development & Safety Assessment Bringing 15 years of nonclinical experience and 12 years with Rani, Kyle’s responsibilities include: ? Overseeing nonclinical efforts, including IND-enabling studies Congratulations to Alireza and Kyle on these well-deserved promotions! We value their leadership and contributions to our success! #Leadership #Promotion #TeamRani #Innovation #RaniPill
-
-
Our CBO Kate Flavin McKinley and CFO Svai Sanford have the honor of presenting in a fireside chat this week at the 2024 Cantor Global Healthcare Conference #CantorHCC. We are excited for the opportunity to share more on how our #RaniPill platform has the potential to replace subcutaneous injection and intravenous infusion of biologics and drugs with oral dosing. Tune in on our webcast: https://bit.ly/4ekUsu9
-
-
On this #LaborDay weekend, we extend our admiration and support to our dedicated employees and our industry colleagues that work hard every day to serve patients and improve lives.?At #RaniTherapeutics our Team is committed to advancing our RaniPill platform to realize our mission to replace subcutaneous injections and intravenous infusion of biologics and drugs with oral dosing. #RaniTherapeutics?#RaniPill?#LaborDay2024
-